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Abstract
Alzheimer’s disease (AD) is a neurodegenerative disorder causing
progressive memory loss and cognitive dysfunction. Anti-AD strategies
targeting cell receptors consider them as isolated units. However, many cell
surface receptors cooperate and physically contact each other forming
complexes having different biochemical properties than individual receptors.
We here report the discovery of dopamine D , histamine H , and N-methyl-
D-aspartate (NMDA) glutamate receptor heteromers in heterologous systems
and in rodent brain cortex. Heteromers were detected by co-
immunoprecipitation and in situ proximity ligation assays (PLA) in the rat
cortex where H  receptor agonists, via negative cross-talk, and H  receptor
antagonists, via cross-antagonism, decreased D  receptor agonist signaling
determined by ERK1/2 or Akt phosphorylation and counteracted D  receptor-
mediated excitotoxic cell death. Both D  and H  receptor antagonists also
counteracted NMDA toxicity suggesting a complex interaction between
NMDA receptors and D -H  receptor heteromer function. Likely due to
heteromerization, H  receptors act as allosteric regulator for D  and NMDA
receptors. By bioluminescence resonance energy transfer (BRET), we
demonstrated that D  or H  receptors form heteromers with NR1A/NR2B
NMDA receptor subunits. D -H -NMDA receptor complexes were confirmed
by BRET combined with fluorescence complementation. The endogenous
expression of complexes in mouse cortex was determined by PLA and similar
expression was observed in wild-type and APP/PS1 mice. Consistent with
allosteric receptor-receptor interactions within the complex, H  receptor
antagonists reduced NMDA or D  receptor-mediated excitotoxic cell death in
cortical organotypic cultures. Moreover, H  receptor antagonists reverted the
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toxicity induced by ß -amyloid peptide. Thus, histamine H  receptors in
D -H -NMDA heteroreceptor complexes arise as promising targets to prevent
neurodegeneration.
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Introduction
Current Alzheimer’s disease (AD) therapies mainly target acetyl cholinesterase
to enhance cholinergic neurotransmission. However, neurodegeneration is not
limited to a specific neurotransmitter system. Glutamatergic, serotonergic,
adrenergic, dopaminergic, and peptidergic neurotransmitter systems are also
deregulated in AD [ 1 ]. Impaired neuronal signaling may affect amyloid
precursor protein (APP) proteolysis and promote amyloid formation in the AD
brain. In addition, amyloid toxicity and neurodegeneration may affect
neurotransmission, suggesting the involvement of complex positive-feedback
loops in the pathogenesis of the disease. Consequently, a complementary
approach that includes modulation of neurotransmission in addition to lowering
the amyloid burden is an attractive therapeutic strategy for the treatment of AD
[ 1 – 3 ]. Indeed, activation of dopamine D -like receptors protects neurons from
1–42 3
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synapse dysfunction induced by amyloid oligomers [4 ] and we and others have
shown that dopamine facilitates hippocampal acetyl-choline release by acting
on D -like receptors that are G protein-coupled receptors (GPCR) located in
hippocampal cholinergic terminals [ 5 – 8 ]. Moreover, activation of dopamine
D  receptors (D R) enables working memory by enhancing the firing of
pyramidal neurons [ 9 , 10 ]. Thus, the dopaminergic system is a key
neurotransmitter system involved in AD. Another key neurotransmitter system
implicated in AD is the histaminergic system [ 11 – 15 ] and GPCR histamine 3
receptors (H R) are widely expressed in the CNS, particularly in the frontal
cortex and hippocampus [ 16 ]. H R antagonists are promising drugs for AD
[ 17 – 19 ] but the exact mode of action is more complex than suspected. One
potential mechanism may be the blockade of histamine receptors in a specific
CNS hetero-oligomeric context. Indeed, hetero-oligomerization of proteins is a
recurrent phenomenon in biology [ 20 , 21 ]. Dopamine D  GPCRs interact in
striatum with inter alia the histamine H  receptor. Whereas D  receptors are
coupled to heterotrimeric G  proteins and histamine H  receptors couple to
G /G , D /H  receptor heteromers (D /H RHets) allow histamine H  receptor
agonists to activate the mitogen-activated protein kinase (MAPK) pathway. The
link between histamine receptors and MAPK depends on heteromer formation
as it does not happen in D  receptor-deficient mice [ 6 , 22 ].
In the case of ionotropic glutamate receptors, formation of hetero-oligomers is
needed for proper function. In transfected cells, N-methyl-D-aspartate (NMDA)
regulates dopamine D  receptor trafficking and desensitization by a direct
interaction between the ionotropic glutamate (NMDA) and the metabotropic
dopamine (D ) receptors [ 23 ]. Lee et al. (2002) showed, also in an heterologous
system, that the cytoplasmic tail of the D  receptor has two epitopes to interact
with NR1-1a and NR2A subunits of the NMDA receptor [24 , 25 ]. The
interaction with NR1-1a affects NMDA receptor-mediated excitotoxicity while
the interaction with NR2A affects ligand-gated currents. Besides inhibitors of
acetyl cholinesterase, the only drug approved for Alzheimer’s disease is
Namendal  whose active component, memantine, is an allosteric modulator of
NMDA receptors [ 26 ], which remain one of the main therapeutic targets in this
neurodegenerative disease [ 27 ]. As heteroreceptor complexes formed by
different GPCRs [ 28 ] or by combination of GPCR and ionotropic receptors
[ 29 ] have specific physiological functions and emerge as novel therapeutic
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targets, the aim of the present paper was to look for heteromers formed by
dopamine D , histamine H , and NMDA receptors and to assess their potential
as targets in Alzheimer’s disease.
Materials and Methods
Animals
Two-month-old male Sprague Dawley rats (animal facility of the Faculty of
Biology, University of Barcelona) were housed two per cage and kept on a
12/12-h dark/light cycle with food and water available ad libitum and
experiments were performed during the light cycle. Animals were anesthetized
with 4 % isoflurane and euthanized by decapitation. APP/PS1 mice and wild-
type (WT) littermates were used. The generation of mice expressing the human
mutated forms of the amyloid precursor protein (APPswe) and presenilin-1
(PS1dE9) is described elsewhere [ 3 ]. In the present study, identification of
transgenic mice was carried out as follows: genomic DNA was isolated from 1-
cm tail clips and genotyped by polymerase chain reaction (PCR) technique
using the PCR conditions proposed by the Jackson Laboratory ( www.jax.org ).
Animals were maintained under standard animal housing conditions in a 12-h
dark–light cycle with free access to food and water. Animal procedures were
conducted according to ethical guidelines (European Communities Council
Directive 2010/63/EU) and approved by the animal experimentation ethics
committee of the Catalan Government (CEEA-DAAM 6419 and CEEA/DMAH
4049 and 5664).
Co-Immunoprecipitation Experiments
Rat cortical tissue was homogenized at 4 °C in 50 mM Tris–HCl buffer, pH 7.4,
containing a protease inhibitor mixture (1/1000, Sigma-Aldrich, St. Louis, MO,
USA) using a Polytron homogenizer, and membranes were obtained by
centrifugation at 105,000g for 1 h at 4 °C. Membranes were washed three more
times at the same conditions and were solubilized by homogenization in ice-
cold immunoprecipitation buffer (phosphate-buffered saline, pH 7.4, containing
1 % (v/v) Nonidet P-40) and incubated for 30 min on ice before centrifugation
at 105,000g for 1 h at 4 °C. Using a Dynabeads® Protein G kit (Invitrogen,
Paisley, Scotland, UK), the supernatant (1 mg/ml of protein) was processed as
described in the immunoprecipitation protocol. Protein content was quantified
1 3
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by the bicinchoninic acid method (Pierce) using bovine serum albumin dilutions
as standard. Immunoprecipitation was carried out with a rat anti-D  receptor
antibody (1:1000, Sigma-Aldrich). As negative control, anti-calnexin antibody
was used (1:1000, BD Biosciences Pharmingen, San Diego, CA, USA).
Immunoprecipitates were separated on a denaturing 10 % SDS-polyacrylamide
gel and transferred onto PVDF membranes to perform western blot assays.
Membranes were probed with guinea pig anti-D  receptor (1:1000, Frontier
Institute, Ishikari, Hokkaido, Japan) and rabbit anti-H  receptor (1:1000, Alpha
diagnostic, San Antonio, Texas, USA) antibodies and the appropriate secondary
antibodies: goat anti-guinea pig-peroxidase (1:20,000, Sigma-Aldrich) and goat
anti-rabbit-peroxidase (1:20,000, Thermo Scientific, Fremont, CA). Bands were
visualized with a LAS-3000 equipment (Fujifilm). Data analysis was performed
by Image Gauge software (version 4.0) and Multi Gauge software (version 3.0).
Preparation of Rat and Mouse Brain Sections and Slices
For PLA experiments, rat and mouse brains were rapidly removed and fixed
with 4 % paraformaldehyde solution for 24 h at 4 °C. Brains were then washed
in PBS, cryo-preserved in a 30 % sucrose solution for 48 h at 4 °C, and stored at
−20 °C until sectioning. Cortical 15-µm thick sections were cut on a freezing
cryostat (Leica Jung CM-3000, Leica Microsystems, Mannheim, Germany) and
mounted on glass slides. For cell death determination and signaling
experiments, the brains were rapidly removed and placed in ice-cold
oxygenated (O /CO : 95/5 %) Krebs-bicarbonate buffer (in millimolars: 124
NaCl, 4 KCl, 1.25 KH PO , 1.5 MgCl , 1.5 CaCl , 10 glucose, and 26
NaHCO ) pH 7.4. The brains were sliced along the coronal plane at 4 °C using
a brain matrix (Zivic Instruments, Pittsburgh, PA, USA). Cortical slices
(500 µm thick) were kept at 4 °C in Krebs-bicarbonate buffer during the
dissection.
Cell Culture, Expression Vectors and Transient
Transfection
Human embryonic kidney (HEK-293 T) cells were grown in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 2 mM L-glutamine,
100 µg/ml sodium pyruvate, 100 units/milliliter penicillin/streptomycin, MEM
non-essential amino acid solution (1/100), and 5 % (v/v) heat-inactivated fetal
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bovine serum (FBS) (all supplements were from Invitrogen). For transfection,
sequences encoding receptors or fusion proteins consisting of the human
receptors fused to Renilla luciferase (Rluc) or to yellow fluorescent protein
(YFP) on the C-terminal end of the receptor (D R-YFP, H R-YFP, CB R-Rluc),
of human (H , D , and CB ) receptors fused to the YFP Venus N-terminal
fragment (n-YFP), or of human (serotonin 5-HT , H , and D ) fused to the
YFP Venus C-terminal fragment (c-YFP) were obtained and characterized as
previously described (Navarro et al. 2008; [ 6 , 7 , 31 , 32 ].
Plasmids encoding human NR1A-Rluc and NR2B were generously provided by
Dr. Julie Perroy from the University of Montpellier (France). HEK-293 T cells
growing in 35-mm diameter six-well plates were transiently transfected with
cDNAs by the ramified polyethylenimine (PEI; Sigma-Aldrich) method. Cells
were incubated (4 h) with cDNAs, ramified PEI (5 ml/mg cDNA of 10 mM PEI)
and 150 mM NaCl in a serum-free medium. After 4 h, the medium was changed
to a fresh complete culture medium. Forty-eight hours after transfection, cells
were washed twice in quick succession in HBSS containing the following (in
millimolars): 137 NaCl, 5 KCl, 0.34 Na HPO  × 12 H O, 0.44 KH PO , 1.26
CaCl  × 2 H O, 0.4 MgSO  heptahydrate, 0.5 MgCl , 10 HEPES, pH 7.4,
supplemented with 0.1 % glucose (w/v), detached by gently pipetting, and
resuspended in the same buffer. To control the cell number, sample protein
concentration was determined using a Bradford assay kit (Bio-Rad) using
bovine serum albumin (BSA) dilutions as standards. HEK-293 T cell suspension
(20 µg of protein) was distributed into 96-well microplates; black plates with a
transparent bottom (Porvair, King’s Lynn, UK) were used for fluorescence
determinations, whereas white opaque plates (Sigma-Aldrich) were used for
bioluminescence resonance energy transfer (BRET) experiments.
Fluorescence Complementation Assays
HEK-293 T cells were transiently co-transfected with the cDNA encoding for
H , D , or CB  receptors fused to the YFP Venus N-terminal fragment (n-YFP)
and 5-HT , H , or D  receptors fused to the YFP Venus C-terminal fragment
(c-YFP). To quantify the amount of reconstituted YFP Venus, cells (20 µg
protein) were distributed in 96-well plates (black plates with a transparent
bottom, Porvair), and emission fluorescence at 530 nm was read in a FluoStar
Optima plate fluorometer (BMG Labtechnologies, Ortenberg, Germany)
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equipped with a high-energy xenon flash lamp, using a 10-nm bandwidth
excitation filter at a 400-nm reading. Protein fluorescence expression was
determined as fluorescence of the sample minus the fluorescence of cells not
expressing the fusion proteins (basal). Cells expressing two receptor-cYFP or
two receptor-nYFP fusion proteins showed similar fluorescence levels to non-
transfected cells.
BRET and BRET with Bimolecular Fluorescence
Complementation
HEK293 T cells were transiently co-transfected with a constant amount of
cDNA encoding for the receptor fused to Rluc and with increasing amounts of
cDNA for the receptor fused to YFP (see figure legends). To quantify receptor-
YFP expression, fluorescence of cells (20 µg protein) was read in a FluoStar
Optima Microplate Fluorometer (BMG Labtechnologies) equipped with a high-
energy xenon flash lamp, using a 10-nm bandwidth excitation filter at 400 nm
reading. For bioluminescent resonance energy transfer (BRET) or BRET with
bimolecular fluorescence complementation (BiFC) measurements, 5 µM
coelenterazine H (Invitrogen) was added to the equivalent of 20 µg of cell
suspension. After adding coelenterazine H (1 min for BRET or 5 min for BRET
with BiFC), readings were collected using a Mithras LB 940 that allows the
integration of the signals detected in the short-wavelength filter at 485 nm
(440–500 nm) and the long-wavelength filter at 530 nm (510–590 nm). To
quantify receptor-Rluc expression, luminescence readings were also performed
after 10 min of adding 5 µM coelenterazine H. The net BRET is defined as
[(long-wavelength emission)/(short-wavelength emission)]−cf., where cf.
corresponds to [(long-wavelength emission)/(short-wavelength emission)] for
the donor construct expressed alone in the same experiment. Data were fitted to
a nonlinear regression equation, assuming a single-phase saturation curve with
GraphPad Prism software. BRET is expressed as milliBRET units (mBU).
Determination of Phospho-Extracellular-Signal Regulated
Kinase (ERK1/2) and Phospho-Akt/Protein Kinase B (PKB)
After dissection, fresh cortical slices were transferred into 1 ml of ice-cold
Krebs-bicarbonate buffer. The temperature was raised to 23 °C and after
30 min, the culture medium was replaced by 2 ml of fresh Krebs-bicarbonate
buffer (23 °C). Slices were incubated under constant oxygenation (O /CO :2 2
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95 %/5 %) at 30 °C for 4–5 h in an Eppendorf thermomixer (5 Prime, Inc.,
Boulder, CO, USA). The medium was replaced by 200 µl of fresh Krebs-
bicarbonate buffer and incubated for 30 min before the addition of any agent.
Slices were treated with the indicated ligand concentration for the indicated
time and lysed with (in millimolars) 50 Tris–HCl pH 7.4, 50 NaF, 150 NaCl,
45 mM glycerol-3-phosphate, 0.02 phenyl-arsine oxide, 0.4 NaVO , and 1 %
Triton X-100 and protease inhibitor cocktail. Cellular debris was removed by
centrifugation at 13,000g for 10 min at 4 °C and total protein was quantified by
the bicinchoninic acid method using bovine serum albumin dilutions as
standard. To determine the degree of protein phosphorylation, equivalent
amounts of protein were separated by electrophoresis on a denaturing 10 %
SDS-polyacrylamide gel and transferred onto PVDF-FL membranes. Odyssey
blocking buffer (LI-COR Biosciences, Lincoln, NE, USA) was then added, and
the membrane was rocked for 90 min. The membranes were then probed
overnight with a mixture of a mouse anti-phospho-ERK1/2 antibody (1:2500;
Sigma-Aldrich), a rabbit anti-phospho-Ser473-Akt antibody (1/2500, SAB
Signalway Antibody, Pearland, Texas, USA), and a rabbit anti-ERK1/2
antibody that recognizes both phosphorylated and unphosphorylated ERK1/2
(1:40,000; Sigma-Aldrich). The 42- and 44-kDa bands corresponding to ERK1
and ERK2 were visualized by the addition of a mixture of IRDye 800 (anti-
mouse) antibody (1:10,000; Sigma-Aldrich) and IRDye 680 (anti-rabbit)
antibody (1:10,000; Sigma-Aldrich) for 2 h and scanned by the Odyssey
infrared scanner (LI-COR Biosciences). Band densities were quantified using
the scanner software and exported to Excel (Microsoft, Redmond, WA, USA).
The level of phosphorylated ERK1/2 isoforms or of pAkt/PKB was normalized
for differences in loading using the total ERK1/2 protein band intensities.
Cell Death Determination in Rat and Mouse Organotypic
Cultures
Immediately after dissection, brain slices (500 µm thickness, see above) were
placed in six-well plates containing Millicell-CM organotypic tissue culture
plate inserts (EMD Millipore Corporation, Billerica, MA, USA) and cultured at
37 °C with Neurobasal medium supplemented with 20 % horse serum, 0.5 %
B27, 2 mM L-glutamine, 100 µg/ml sodium pyruvate, MEM non-essential
amino acid solution (1/100), and 100 units/milliliter penicillin/streptomycin (all
supplements were from Invitrogen). After 24 h, culture medium was replaced
4
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by fresh medium containing no ligands or the indicated concentrations of SKF-
81297, SCH-23390, NMDA, MK-801, or thioperamide 1 h before the addition
of the excitotoxic agents (D  or NMDA receptor agonists at 50 µM). Slices
were maintained 48 h more in culture and, after a total 72 h of incubation,
10 µM propidium iodide (PI) was added to culture medium, which was
maintained at 37 °C for 1 h. Slices were then removed from the incubator,
washed twice in cold-PBS and fixed with 4 % paraformaldehyde for 1 h at 4 °C.
Nuclei were stained with 1:1000 Hoechst for 1 h. Total (Hoechst-stained) and
PI-positive nuclei were quantified to evaluate cell death using Leica SP2
confocal microscope (20×; UV, 561 lasers) and the quantification program
Image-based Tool for Counting Nuclei for ImageJ.
In Situ Proximity Ligation Assays (PLA)
Rat or mouse cortical brain sections were mounted on glass slides, thawed at
4 °C, washed in 50 mM Tris–HCl, 0.9 % NaCl pH 7.8 buffer (TBS),
permeabilized with TBS containing 0.01 % Triton X-100 for 10 min, and
repeatedly washed with TBS. Heteromers were detected using the Duolink II in
situ proximity ligation assays (PLA) detection Kit (Sigma-Aldrich) following
the instructions of the supplier. To detect D -H , NMDA/NR1-D , or
NMDA/NR1-H  heteroreceptor complexes, we used a mixture of equal amounts
of the following pairs of primary antibodies: (i) guinea pig anti-D  receptor
(Frontier Institute, Hokkaido, Japan) and rabbit anti-H  (Alpha diagnostic)
receptors, (ii) guinea pig anti-D  and rabbit anti-NMDA/NR1 (Abcam Inc.,
Cambridge, MA, USA) antibodies, or (iii) rabbit anti-NMDA/NR1 antibody
directly coupled to a minus DNA chain and rabbit anti-H  receptor antibody
directly coupled to a plus DNA chain (obtained following the instructions of the
Sigma-Aldrich supplier). PLA probes detecting guinea pig or rabbit antibodies
were used to detect D -H  and NMDA/NR1-D  receptor complexes. Then
samples were processed for ligation and amplification and were mounted using
a DAPI-containing mounting medium. Samples were observed in a Leica SP2
confocal microscope equipped with an apochromatic 63X oil-immersion
objective (N.A. 1.4), and a 405-nm and a 561-nm laser lines. For each field of
view a stack of two channels (one per staining) and six to seven Z stacks with a
step size of 1 µm were acquired. Quantification of cells containing one or more
red spots versus total cells (blue nucleus) and, in cells containing spots, the
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ratio r (number of red spots/cell) were determined, using the Fiji package (
http://pacific.mpi-cbg.de/ ), considering a total 1000–2000 cells from 7 to 16
different fields from three different animals. Nuclei and red spots were counted
on the maximum projections of each image stack. After getting the projection
each channel was processed individually. The nuclei were segmented by
filtering with a median filter, subtracting the background, enhancing the
contrast with the Contrast Limited Adaptive Histogram Equalization (CLAHE)
plug-in, and finally applying a threshold to obtain the binary image and the
regions of interest (ROI) around each nucleus. Red spot images were also
filtered and thresholded to obtain the binary images. Red spots were counted in
each of the ROIs obtained in the nuclei images. The number of red dots after
PLA was negligible in the negative controls constituted by sections only
incubated with one primary antibody (anti-D R in rat and mouse slices and anti-
H R in mouse slices).
Statistical Analysis
The data in the graphs are presented as the mean#±#SEM. Statistical analysis was
performed with SPSS 18.0 software. The test of Kolmogorov–Smirnov with the
correction of Lilliefors was used to evaluate the fit of the data to a normal
distribution and the test of Levene to evaluate the homogeneity of variance.
Significance was analyzed by two-way or one-way ANOVA followed by post
hoc test (see figure legends) for multiple comparisons. Significant differences
were considered when p#<#0.05.
Results
Identification of Heteromers in Brain Cortex
D /H  heteroreceptor complexes (D /H RHets) have been described in the
striatum [ 22 ]. In an attempt to identify D /H RHets in the cerebral cortex, co-
immunoprecipitation and in situ proximity ligation assays (PLA) were
performed in rat samples. Detergent extracts from rat cortex were
immunoprecipitated with antibodies against D  receptors and immunoblotted
using either anti-D  or anti H -receptor antibodies. Results depicted in Fig. 1a–
c  indicate that immunoprecipitates contained both receptors. The in situ
proximity ligation assay (PLA), which allows detection of proteins in close
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proximity, confirmed in cortical sections that D  and H  receptors form
aggregates, detected as red dots in some of the neural cells (Fig. 1d ). The
number of red dots after PLA was negligible in the negative controls constituted
by sections only incubated with one primary antibody (anti-D  receptor
antibody; Fig. 1e ).
Fig. 1
Detection of D -H  receptor heteromers in samples from rat cortex. Co-
immunoprecipitation experiments (a–c) and PLA (d, e) were performed in
samples from rat cortex. Solubilized rat cortical membranes (a) and
immunoprecipitates with anti-D  receptor or anti-calnexin antibodies as negative
control (NC) (b, c) were analyzed by SDS-PAGE and immunoblotted using anti-
D  or anti-H  receptor antibodies. IP immunoprecipitation, WB western blotting,
MW molecular weight. PLA experiments were performed as indicated in
“Materials and Methods” and D /H  receptor complexes (d) were visualized as
red spots around blue-colored DAPI-stained nucleus; the negative control (e) was
performed in sections incubated with one primary antibody (against the D
receptor). Scale bar: 20 µm
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As previously reported, D /H RHets may couple to the MAP kinase pathway
[ 22 ]. Slices from rat cortex were incubated (8 min) with agonists, and ERK1/2
and Akt phosphorylation were assayed. Activation of D  or H  receptors using,
respectively, 1 µM SKF-81297 or 1 µM imetit, led to significant ERK1/2
phosphorylation that was blocked by their respective selective antagonists
(10 µM SCH-23390 or thioperamide). Interestingly, the antagonist of D
receptors blocked the effect of H  receptor agonists and the antagonist of H
receptors blocked the effect of D  receptor agonists (Fig. 2a ). Fairly similar
results were obtained on analyzing pAkt data (Fig. 2b ). Such cross-antagonism
is a common feature of receptor heteromers that may be considered as a
D /H RHet print.
Fig. 2
a, b Signaling cross-talk and cross-antagonism on ERK 1/2 and Akt
phosphorylation in rat cortical slices. Slices were preincubated with Krebs-
bicarbonate buffer or antagonists (10 µM thioperamide or 10 µM SCH-23390) for
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20 min prior to the addition of agonists (1 µM SKF-81297), followed by a further
incubation of 10 min. ERK1/2 or Akt phosphorylation was determined as
described in “Materials and Methods .” For each treatment, the immunoreactive
bands from eight slices obtained in two different experiments from a total of ten
animals were quantified, and values represent the mean#±#SEM of the percentage
of phosphorylation relative to basal levels found in untreated slices (100 %).
Significant differences were calculated by one-way ANOVA with post hoc
Bonferroni’s test for multiple comparisons (***p#<#0.001 compared with the
control condition; p#<#0.001 compared with SKF-81297 treatment; &&&p#<#
0.001 compared with imetit treatment)
AQ2
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Since previous reports from different laboratories [23 , 24 ] have described the
in vitro interaction between the NR1A subunit of NMDA receptor and D
receptors, we investigated by PLA whether aggregates formed by NMDA and
D  receptors or NMDA and H  receptors could be detected in sections from rat
cortex. PLA experiments were performed in rat cortical sections using
antibodies specific for the two GPCRs and for the NR1A subunit. PLA data
indicated the existence of NR1A-D  or NR1A-H  receptors in close proximity
(Fig. 3a, b ). Very few red dots were found in negative controls performed with
primary antibodies against D , Fig. 1e , or against H  receptors (not shown).
Overall, these results indicate that the three proteins, D , H , and NMDA
glutamate receptors, may be as close as to form heteromeric complexes in the
brain cortex.
Fig. 3
Detection of NR1-D  and NR1-H  receptor complexes in rat cortex. PLA
experiments were performed in rat cortical sections as indicated in “Materials and
Methods .” NMDA/NR1A-D  (a) and NMDA/NR1A-H  (b) receptor complexes
were visualized as red spots around blue-colored DAPI-stained nucleus. Scale
bar: 20 µm
In Vitro Identification of Heteromers Formed by D , H ,
and NMDA Receptors
The next aim was to establish whether D , H , and NMDA receptors could form
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heteromeric complexes in heterologous cells expressing the three receptors. To
attempt to identify the formation of direct interactions involving these
receptors, a combination of bioluminescence resonance energy transfer (BRET)
and bimolecular fluorescence complementation (BiFC) was undertaken. HEK-
293 T cells were transfected with cDNAs encoding for fusion proteins formed
by Rluc or YFP and the whole open reading frame of D , H , or the NR1A
subunit of NMDA receptors. Cells expressing the NR1A subunit fused to Rluc
and D R-YFP provided a saturable BRET signal that proves the interaction
between the two proteins (Fig. 4b ). BRET  was 7.0#±#0.7 mBU and BRET
was 51#±#2 mBU (mean#±#SD; n#=#3–6). As the NR2B subunit is needed for
surface expression of NMDA receptors, the experiment was repeated in cells
expressing NR1A and NR2B subunits. BRET signal was saturable indicating
that NR1A-Rluc does interact with D -YFP even in the presence of the third
protein (Fig. 4c ). BRET  was 20#±#10 mBU and BRET  was 70#±#20 mBU
(mean#±#SD; n#=#3–6). Different BRET  values in the absence and presence of
NR2B subunit indicate that the hetero-oligomer forms with a different affinity.
BRET data using H  and NMDA receptors were qualitatively different. On the
one hand, the NR1A-Rluc subunit did not provide specific BRET readouts when
transfected with H -YFP receptors, i.e., the relationship with the acceptor/donor
ratio was linear, thus showing a lack of interaction (Fig. 4d ). On the other hand,
BRET between NR1A-Rluc and H -YFP converted into saturable when the
NR2B subunit was co-expressed (Fig. 4e ). Taken together, data indicate that H
and D  receptors may form a complex with functional NR1A/NR2B NMDA
receptors. Importantly, evidence for complexes having the three receptors was
obtained by the dopamine-induced increase of BRET  between NR1A-Rluc
and H -YFP (in the presence of D  and NR2B) (Fig. 4f ). To know whether a
macromolecular complex may include the four proteins, a BRET with
bimolecular fluorescence complementation assay was performed. For
complementation experiments, different ratios of plasmids encoding fusions
proteins constituted by H  or D  receptors and one half of the YFP (H R-nYFP
and D R-cYFP) were assayed to optimize fluorescence emission after
complementation (ESM 1 : Fig. S1a, b). The optimal cDNA ratio was 1.5 and
4 µg for, respectively, plasmids coding H R-nYFP or D R-cYFP or (ESM 1 :
Fig. S1). The assayed negative controls were those constituted by non
interacting pairs: serotonin 5HT  and H  receptors fused to, respectively, the
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C-terminal and N-terminal hemi-domains of YFP, or cannabinoid CB  and D
fused to, respectively, the N-terminal and C-terminal hemi-domains of YFP
(ESM 1 : Fig. S1). Cells were then transfected with cDNAs encoding for
NR1A-Rluc, NR2B, and H  and D  receptors fused to, respectively, the N-
terminal and C-terminal hemi-domains of YFP. Complementation was
confirmed by a saturable BRET signal (Fig. 4h ), thus demonstrating the
formation of a macromolecular complex containing D , H , and NMDA
receptors. The negative control in cells co-expressing CB R-Rluc, D R-cYFP,
and H R-nYFP led to a linear non-specific BRET reflecting the inability of the
cannabinoid CB  receptor to interact with D /H RHets (Fig. 4h ).
Fig. 4
Detection by energy transfer experiments of complexes formed by of NR1A and
D  and H  receptors. a Scheme of the BRET technique. One receptor (R1) fused
to Rluc (BRET donor) and a closely located receptor (R2) fused to YFP (BRET
acceptor) allows, prior addition of a Rluc substrate, energy transfer, and
fluorescence emission at 530 nm. b–e BRET saturation experiments were
performed using HEK293 T cells 48 h post-transfection with 0.2 µg of cDNA for
NR1A-Rluc with (c, e) or without (b, d) the same amount of cDNA for NR2B and
increasing amounts of cDNA for to D R-YFP (0.5–4.5 µg cDNA) (b, c) or H R-
YFP (0.5–4.5 µg cDNA) (d, e). f As in e but in cells also transfected with 2 µg of
cDNA for D  receptors (full human version) and treated with 1 µM of dopamine.
g Scheme of BRET combined with bimolecular fluorescence complementation
(BiFC) to detect D R-H R-NMDA receptor heteromers. In this assay, the BRET
donor consists of Rluc fused to the NR1A NMDA receptor subunit (orange). The
acceptor for BRET (YFP Venus) is reconstituted if H R (blue) fused to the N-
terminal half of YFP is close to D R (green) fused to the C-terminal half of YFP
Venus. h BRET with bimolecular fluorescence complementation (BiFC)
experiments were carried out 48 h post-transfection using 0.05 µg of cDNA for
NR1A-Rluc and to NR2B (or 0.08 µg of cDNA for CB R-Rluc) and increasing
amounts of cDNA for H R-nYFP (0.5–6 µg cDNA) and D R-cYFP (0.5–3 µg
cDNA). Both fluorescence and luminescence of each sample were measured in
every experiment to confirm similar donor expressions (∼130,000
bioluminescence units) while monitoring the increase in acceptor expression
(10,000–40,000 fluorescence units in BRET saturation experiments and 10,000–
25,000 fluorescence units in BiFC experiments). The relative amount of BRET is
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given as a function of 100 × the ratio between the fluorescence of the acceptor
(YFP) and donor (Rluc) expression. BRET and BiFC are expressed as milliBRET
units (mBU) and values are the mean#±#SEM from four to ten different
experiments grouped as a function of the amount of acceptor
In Vitro Neuroprotection
The effect on NMDA-mediated excitotoxicity of D  and H  receptor ligands
was tested in slices from rat cortex. Images comparing Hoechst and propidium
iodide labeling are shown in Fig. 5  (top). Quantification of dead versus total
cells showed that NMDA but also SKF-81297, a full D  receptor agonist, were
able to significantly induce cell death (Fig. 5 , bottom). A selective NMDA
antagonist, MK-801, partially reversed the SKF-81297-induced toxicity. The D
receptor selective antagonist, SCH-23390, and, interestingly, the selective H
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receptor antagonist, thioperamide, were able to markedly reduce the toxicity
induced by NMDA (Fig. 5 , bottom).
Fig. 5
Functional interactions between D , H , and NMDA receptors at the level of
excitotoxic cell death in rat brain organotypic cultures. Organotypic cultures of
rat cortical slices were prepared as indicated in “Materials and Methods .”
Twenty-four hours post-dissection, culture medium was replaced by fresh
medium containing vehicle or 10 µM SCH-23390, MK-801, or thioperamide.
Slices were incubated for 1 h before the addition of the D  receptor agonist SKF-
81297 (50 µM) or NMDA (50 µM) and samples were maintained 48 h more in
culture. Cell death was determined by comparing Hoechst and propidium iodide
(PI) staining as indicated in “Materials and Methods .” Top: Representative
images of control (basal) and treated (NMDA and NMDA plus thioperamide)
samples. Bottom: Values represent mean#±#SEM of the percentage of PI-stained
cells versus total Hoechst-stained cells (the 100 % value would represent all cell
death) determined in 10–12 fields from three independent organotypic cultures.
Scale bars: 20 µm. One-way ANOVA followed by Bonferroni’s post hoc test
showed a significant effect over vehicle-treated (***p#<#0.001), SKF-81297-
treated ( p#<#0.05, p#<#0.001), or NMDA-treated (&&&p#<#0.001) cultures
1 3
1
# ###
21/06/16 08:08e.Proofing
Página 20 de 35http://eproofing.springer.com/journals/printpage.php?token=3jh_UUTHp-BkXBRBDjF2T3t3RTPovJCYBdOqpB8AhPM
Similar experiments were performed in slices from a transgenic model of
Alzheimer’s disease, namely the APP/PS1 mouse. Brain cortical slices from
APP/PS1 and age-matched non-transgenic (wild-type) animals were treated
with NMDA or SKF-81297 to provoke excitotoxic neuronal cell death. The two
drugs led to a significant cell death in samples from the two animal groups that
was prevented by 10 µM MK-810, the selective NMDA receptor antagonist.
The antihistamine drug (10 µM thioperamide) also led to a significant
prevention of excitotoxic damage. Neuroprotection was also afforded by
thioperamide in samples from APP/PS1 animals treated with SKF-81297. In
addition, the D  receptor selective antagonist SCH-23390 also counteracted the
death induced by NMDA (Fig. 6a, b ). Overall, neuroprotection data show the
interplay between the three receptors and that antagonists may prevent
excitotoxic neuronal death.
Fig. 6
Functional interactions between D , H , and NMDA receptors at the level of
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excitotoxic cell death in organotypic cultures from APP/PS1 and age-matched
wild-type mice. Organotypic cultures of cortical slices from wild-type (a) and
APP/PS1 (b) mice were prepared as indicated in “Materials and Methods .”
Cultures in fresh medium containing vehicle or 10 µM SCH-23390, MK-801, or
thioperamide were then incubated for 1 h before the addition of the D  receptor
agonist SKF-81297 (50 µM) or NMDA (50 µM) and samples were maintained
48 h more in culture. Cell death was determined by Hoechst and propidium iodide
(PI) staining as indicated in “Materials and Methods .” Values represent mean#±#
SEM of the percentage of PI-stained cells versus total Hoechst-stained cells (the
100 % value would represent all cell death) determined in 10–12 fields from three
independent organotypic cultures. One-way ANOVA followed by Bonferroni’s
post hoc test showed a significant effect over vehicle-treated (***p#<#0.001),
SKF-81297-treated ( p#<#0.001), or NMDA-treated (&&&p#<#0.001)
organotypic cultures. Two-way ANOVA showed no significant differences on
comparing data from wild-type and APP/PS1 mice
Expression of Heteromers in Cortex from APP/PS1 Mice
Unfortunately, there is not any reliable methodology to detect three interacting
proteins in natural sources. Thus, the potential expression of macromolecular
complexes in cortex was addressed by PLA assays aimed at detecting
heteromers between pairs of proteins. Using combinations of antibodies,
macromolecular complex expression was assayed in the cortex of wild-type and
APP/PS1 mice, which exhibits an accelerated AD phenotype due to
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overexpression of the human amyloid precursor protein harboring the Swedish
double mutation and of the presenilin-1 L166P mutant. Red dots reflecting
positive PLA were observed in samples treated with antibodies against D  and
H  receptors, with antibodies against D  and NR1A receptors and with
antibodies against H  and NR1A. The number of red dots after PLA was
negligible in the negative controls, obtained by doing the PLA experiments in
wild-type and APP/PS1 mice brain sections only incubated with antibodies
against D  (Fig. 7a, b ) or against H  receptors (not shown). In cortical sections
from wild-type mice, the percentage of cells expressing D -H , NMDA/NR1A-
D , or NMDA/NR1A-H  complexes was similar; also similar were the dots/cell
ratios (Fig. 7b , black bars). Although indirect, these PLA results constitute
evidence that the three receptors form a macromolecular complex. The
percentage of dimer-expressing cells was also similar in the cortex from the
APP/PS1 mouse (Fig. 7b  left, red bars) also suggesting the occurrence in the
cortex of APP/PS1 animals of complexes formed by the two GPCRs and the
NR1A subunit of the NMDA receptor. Differences in the labeling of the three
different pair of proteins between wild-type and APP/PS1 animals were
statistically significant but small in magnitude (circa 10 %). Thus, it may be
assumed that the differences in the expression of complexes formed by the three
proteins are low. Looking at red spots/cell ratios, the highest change in
transgenic versus wilt-type animals is the expression of dimers formed by H
receptors and the NR1A subunit. Such increase correlated with a small increase
in the ratio of D -NR1A pairs and a small increase in the ratio of H -NR1A
pairs (Fig. 7b , right panel). These results highlight the occurrence in the cortex
of the AD mouse of pairs of proteins, and allegedly of complexes of the three
receptors, at levels comparable to those found in samples from wild-type
animals. Due to the relevance of Aß peptide toxicity in Alzheimer’s disease
pathophysiology, we assayed whether the H  receptor antagonist could be
neuroprotective against the toxic action of Aß. Images comparing Hoechst and
propidium iodide labeling are shown in Fig. 8  (top), and the results showed that
10 µM thioperamide was totally effective in blocking the toxic effect of 1 µM
Aß  peptide (Fig. 8 , bottom). Similar effects were obtained with other
selective H  receptor antagonists (not shown). Our results suggest hetero-
oligomer formation in cortex from wild-type and APP/PS1 animals and show
that antagonists of dopamine or of histamine receptors consistently afford
neuroprotection against excitotoxic agents or Aß  peptide.
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Fig. 7
Detection of D -H , NR1A-D , and NR1A-H  receptor complexes in APP/PS1
and age-matched wild-type mice. D -H , NR1A-D , and NR1A-H  receptor
complexes were visualized by PLA as red spots around blue-colored DAPI-
stained nucleus in cortical sections from wild-type (a, top) and APP/PS1 mice (a,
bottom). As negative control (a, left), PLA experiments were performed in
sections incubated with one primary antibody (against the D  receptor). Scale bar:
20 µm. In b (left), a graph shows the number of cells containing one or more red
spots, expressed as a percentage respect the total number of cells (blue nucleus).
The graph in the right shows r values (number of red spots/cell containing spots).
Data are mean#±#SEM of counts in 1000–2000 cells from 7–16 different fields
from each condition from three different animals. One-way ANOVA followed by
Dunnett’s post hoc test showed significant differences (**p#<#0.01, ***p#<#0.001)
on percentage of positive cells and ratio respect to negative control (D ). Two-
way ANOVA after Bonferroni’s post hoc test comparing data from wild-type and
APP-PS1 mice showed significant differences ( p#<#0.05, p#<#0.01, p#<#0.001)
in percentage of cells expressing PLA for any protein pair, and in the number of
spots/cell for D -H , ( p#<#0.05) and NR1A-H  ( p#<#0.001) but not for NR1A-
D  heteroreceptor complexes
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Fig. 8
Aβ  peptide-promoted cell death in rat brain organotypic cultures. Organotypic
cultures of rat cortical slices were prepared as indicated in “Materials and
Methods .” Cultures in fresh medium containing vehicle or 10 µM of SCH-23390
or thioperamide were incubated for 1 h before the addition of Aβ  peptide
(1 µM) and samples were maintained 48 h more in culture. Top: Representative
images of control (basal), and treated (Aβ  peptide and Aβ  peptide plus
thioperamide) samples. Bottom: Cell death was determined by Hoechst and
propidium iodide (PI) staining as indicated in “Materials and Methods .” Values
represent mean#±#SEM of the percentage of PI-stained cells versus total Hoechst-
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stained cells (the 100 % value would represent all cell death) determined in 10–12
fields from three independent organotypic cultures. One-way ANOVA followed
by Bonferroni’s post hoc test showed a significant effect over vehicle-treated
(***p#<#0.001) or Aβ  peptide-treated ( p#<#0.001) organotypic cultures.
Scale bars: 20 µm
Discussion
Dopamine and NMDA receptor interactions have potential from a therapeutic
point of view. A main issue on targeting post-synaptic receptors with agonist or
antagonists is the alteration of important neural functions (reviewed in [ 25 ]).
Activation of D  and NMDA receptors converge in the ERK1/2 MAP kinase
cascade [ 33 ]. pERKs translocate to the nucleus and engage transcription factors
involved in neural plasticity and survival or death mechanisms.
Neural cell toxicity by dopamine is mediated by both cell surface receptors [34 ,
35 ] and by intracellular metabolism leading to increased NAD(P) /NAD(P)H
ratios (Giménez-Xavier et al. 2006 and references therein) [ 37 ]. Reported a
dopamine-induced increase in cytosolic SULT1A1/3 sulfotransferase levels, the
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enzyme that metabolizes the neurotransmitter to dopamine-sulfate. Induction of
sulfotransferases is preceded by dopamine-receptor-mediated ERK
phosphorylation and inhibited by the D  receptor antagonist SCH-23390.
Interestingly, induction of SULT1A1/3 requires NMDA receptor signaling thus
suggesting a dopamine D -NMDA receptor-mediated mechanism [ 37 ].
The quaternary structure of receptor complexes is a key for signaling to the
MAP kinase cascade [ 38 ]. The NR1A and NR2A subunits of the NMDA
receptor interact with two regions in the carboxyl tail of the D  receptor.
Interestingly, one interaction is involved in modulating receptor-gated currents
and the other in the attenuation of NMDA receptor-mediated excitotoxicity
[ 24 ]. Our results suggest the formation of heteromers formed by D , H , and
NR1A-NR2B NMDA receptors in which the quaternary structure of the
complex allows close contacts between D  and H  receptors and the two NMDA
receptor subunits. PLA studies in cortical sections from rats and mice, including
the APP/PS1 transgenic line, showed aggregates formed by NMDA, D  and/or
H  receptors that are suggestive of complexes formed by the three receptors.
Indeed, in vitro assays using BRET and bimolecular fluorescence
complementation constitute evidence of complexes containing D , H , and
NR1A-NR2B NMDA receptors. Dopamine-induced increase of BRET
between NR1A-Rluc and H -YFP (in the presence of the NR2B subunit and the
D  receptor) reflects the allosteric interactions expected when one receptor
within the hetero-oligomer is activated. Alteration of the quaternary structure of
the overall macromolecular complex by H  receptor antagonists seems to
uncouple the death program induced by engagement of D  or NMDA receptors
(Fig. 9 ). The protection afforded in rat cortical slices by the H  receptor
antagonist, thioperamide, was virtually complete. It is worth noting that
thioperamide in cortical slices from APP/PS1 mice reverted the excitotoxic
shock. Although not statistically significant, there was a tendency of
thioperamide decreasing the degree of death in APP/PS1 slices incubated with
medium lacking any added compound. The neuroprotection exerted by
thioperamide in wild-type and APP/PS1 mice was very similar, being this result
consistent with the similar level of expression of D /H , D /NR1A, or
H3/NR1A pairs of proteins in the cerebral cortex from both animal groups.
Assessment of the degree of expression of complexes formed by the three (D ,
H , and NMDA) receptors cannot be direct. Hence, extrapolating the pairwise
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PLA results in Fig. 7 , it is likely that the differences in percentage of cells or
red spots/cell shown would account for a maximum difference of 10 % in the
expression of triple complexes in AD versus wild-type mice. Remarkably, the
evidence of marked D -H -NMDA receptor complex expression in mice
exhibiting an accelerated AD phenotype due to overexpression of the human
amyloid precursor protein make these complexes attractive to combat amyloid-
related excitotoxic damage. The increased excitotoxic vulnerability by amyloid
protein [ 39 ] and evidence of Aß binding to NMDA receptors [ 5 , 40 , 41 ],
prompted the assay of Aß toxicity that was also prevented by thioperamide.
Taken together, the results indicate a neuroprotective potential of H  receptor
antagonists.
Fig. 9
Scheme depicting how complexes formed by NMDA, D , and H  modulate
excitotoxic or Aβ1-42 peptide-mediated cell death. Over stimulation D R by the
SKF-81297 agonist (top panels) induce cell death that can be reverted by H R
antagonist thioperamide. Similarly, NMDA binding to its receptor, or Aβ1-42
peptide, probably by binding to NMDA receptors (bottom panels), induce
excitotoxic cell death that can be reverted by H R antagonist thioperamide.
Neuroprotection seems to involve a cross-antagonism, i.e., thioperamide-
counteracting D  or NMDA receptor overstimulation
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Passaia and Blandina [ 42 ] reviewed data suggesting modulation by histamine
via H  receptors of cholinergic tone in the cortex and hippocampus and
proposed the use of thioperamide as a potential pharmacological intervention to
enhance cholinergic input in AD. To our knowledge, thioperamide has not been
tested in AD animal models. However, recently released results from a 16-week
phase II clinical trial in subjects with mild-to-moderate AD [ 43 ] show that a
monotherapy with GSK239512, a safe and brain-penetrant selective H  receptor
antagonist, improves episodic but not working memory or executive functions.
Although the cognitive effects were virtually absent in these patients, the
potential of H  receptor antagonists to prevent disease progression may not be
underestimated, and our in vitro results show that H  receptor antagonism is
very efficacious in preventing excitotoxicity and Aß peptide toxicity. What the
results suggest is that H  receptor antagonists may not be suitable for what they
have been tested until now, namely cognitive enhancement, but for
neuroprotection, which is seemingly afforded by targeting H -D -NMDA
receptor heteroreceptor complexes.
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Fig. S1 Bimolecular fluorescence complementation optimization. Different ratios
of plasmids encoding fusion proteins constituted by H  or D  receptors and either
half of the YFP were assayed to optimize fluorescence emission after
complementation. HEK293T cells were co-transfected with the indicated amounts
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of cDNAs and 48 h post-transfection, fluorescence was determined at 530 nm.
The optimal combination of cDNAs was obtained using D R-cYFP and H R-
nYFP (a), where the ratio 1.5 µg and 4 µg, respectively, showed the highest
percentage of fluorescence emission respect to non-transfected cells. The inverse
combination of cDNAs D R-nYFP and H R-cYFP (b) showed no significant
differences compared to non-transfected cells in all the tested ratios. As negative
controls, other non-interacting pairs of receptors were assayed: serotonin 5HT
and H  receptors fused to, respectively, the C-terminal and N-terminal hemi-
domains of YFP (c), and cannabinoid CB  and D  fused to, respectively, the N-
terminal and C-terminal hemi-domains of YFP (d). . All negative controls showed
no significant differences compared to non-transfected cells. Values are means ±
SEM of 3–5 different experiments. One-way ANOVA followed by Dunnett’s
post-hoc test showed significant (*p<0.05, ***p< 0.001,) differences compared to
non-transfected cells. (TIFF 1241 kb)
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